ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2022
The PRIMARY Score: Using Intraprostatic
Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07168616 (Prospective Evaluation of Istanbul PSMA PET/CT Criteria for Selecting Candidates for Active Surveillance in Low-Risk Prostate Cancer), which is not on this map. Cited by 128 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Prospective Evaluation of Istanbul PSMA PET/CT Criteria for Selecting Candidates for Active Surveillance in Low-Risk Prostate Cancer
Who cites it
128 citing papers in PubMed, 2 syntheses or guidelines pooled it, 105 citations in OpenAlex.
- The predictive value of PSMA PET/CT in determining pathological upgrading of prostate cancer: A pooling up analysis.Frontiers in oncology · 2025Pooled it
- Novel non-MRI imaging techniques for primary diagnosis of prostate cancer: micro-ultrasound, contrast-enhanced ultrasound, elastography, multiparametric ultrasound, and PSMA PET/CT.Prostate cancer and prostatic diseases · 2024Pooled it
- Focal therapy using a novel cooled laser device for prostate cancer: early trial results.BJU international · 2026Trial
- [European journal of nuclear medicine and molecular imaging · 2026Trial
- Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET-Targeted Prostate Biopsy for Prostate Cancer Diagnosis.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025Trial
- Prospective comparison ofEuropean journal of nuclear medicine and molecular imaging · 2025Trial
- External validation of the P-Score in the prospective, pre-biopsy DEPROMP cohort: integrated mpMRI and PSMA PET/CT risk stratification for prostate cancer detection.European journal of nuclear medicine and molecular imaging · 2026Article
- Intense Focal Peripheral Uptake Pattern on 18F-PET/PSMA as a Predictor of Histological Upgrading in Prostate Cancer.The Prostate · 2026Article
- Prostate biopsy - current discussions and future perspectives.Prostate cancer and prostatic diseases · 2026Review
- Prospective evaluation of the PRIMARY score using [European journal of nuclear medicine and molecular imaging · 2026Article
- Feasibility and early outcomes of salvage robot-assisted radical prostatectomy after focal therapy failure for localized prostate cancer.Translational andrology and urology · 2026Article
- Limited incremental prognostic value of pretreatment MRI andAbdominal radiology (New York) · 2026Article
- Development and validation of a preoperativeEuropean journal of nuclear medicine and molecular imaging · 2026Article
- PSMA PET/CT-Targeted Biopsy in Men with Negative or Equivocal Multiparametric MRI and Exploratory Dynamic Total-Body PET: The FUPERMAN Study.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026Article
- PSMA PET: the answer to MRI-occult prostate cancer… or another mirage?European radiology · 2026Review
- Article
- Comparative analysis of PSMA-RADS Version 2.0 versus bone uptake metastatic probability (BUMP) score for characterising focal bone uptake on [18F]PSMA-1007 PET/CT in prostate cancer - a multicentre evaluation.European journal of nuclear medicine and molecular imaging · 2026Article
- Prostate specific membrane antigen focal ablation imaging (PSMA-FAB).Prostate cancer and prostatic diseases · 2026Review
- Diagnostic impact of interpretation criteria for [European journal of nuclear medicine and molecular imaging · 2026Article
- Identifying Candidates for Biopsy Omission in Prostate Cancer Using mpMRI and PSMA PET/CT.European urology open science · 2026Article
68 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 10 institutions in 3 countries.
Funding
Abstract
Multiparametric MRI (mpMRI) is validated for the diagnosis of clinically significant prostate cancer (csPCa).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.